Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:07 PM
Ignite Modification Date:
2025-12-24 @ 11:07 PM
NCT ID:
NCT04028869
Eligibility Criteria:
Inclusion Criteria:
* 1\) Patients with autoimmune liver disease: All enrolled autoimmune liver diseases meet the diagnostic criteria of China's Consensus on Diagnosis and Treatment of Autoimmune Liver Disease (2015);
* 2\) no hormones and / or immunosuppressants and other liver protection drugs;
* 3\) Sign the written informed consent form.
Exclusion Criteria:
* 1\) Combine other hepatitis virus (HCV, HDV) infections;
* 2\) viral liver disease;
* 3\) HIV infection;
* 4\) long-term alcohol abuse and / or other liver damage drugs;
* 5\) mental illness;
* 6\) Evidence of liver tumors (liver cancer or AFP \> 100 ng/ml);
* 7\) decompensated cirrhosis;
* 8\) Serious diseases such as heart, brain, lung, kidney, etc. can not participate in long-term follow-up;
* 9\) There are hormones and / or immunosuppressants and other liver protection drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04028869
Study Brief:
Protocol Section:
NCT04028869